2018
DOI: 10.1055/s-0038-1653944
|View full text |Cite
|
Sign up to set email alerts
|

Past and Present: A Review of Antenatal Corticosteroids and Recommendations for Late Preterm Birth Steroids

Abstract: Since 1972, the beneficial neonatal effects of antenatal corticosteroids (ACSs) have been repeatedly demonstrated in pregnancies at risk of preterm birth before 34 weeks' gestation. While ACS utilization before 34 weeks has been high since the 1990s, knowledge gaps regarding the risks and benefits of ACS continue to exist. Recent evidence has been published regarding the benefit of ACS in the late preterm period. This review addresses the evidence and knowledge gaps for ACS use before and after 34 weeks' gesta… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
2
0
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(4 citation statements)
references
References 109 publications
0
2
0
1
Order By: Relevance
“…Some studies support improved respiratory outcomes for infants administered steroids in the late preterm period, while others do not show these improved outcomes and instead demonstrate an increased risk of adverse outcomes, such as neonatal hypoglycemia and sepsis. 47 48 49 50 51 Data regarding rescue course of steroids is similarly inconsistent. 52 53 54 55 56 57 Given these inconsistencies regarding perinatal benefit to late preterm and rescue ACS, as well as the suppression of the maternal immune response associated with steroid administration, we recommend all late preterm antenatal steroids and rescue courses to be withheld during the pandemic.…”
Section: Limited Use Of Antenatal Corticosteroids Beyond 34 Weeks or mentioning
confidence: 99%
“…Some studies support improved respiratory outcomes for infants administered steroids in the late preterm period, while others do not show these improved outcomes and instead demonstrate an increased risk of adverse outcomes, such as neonatal hypoglycemia and sepsis. 47 48 49 50 51 Data regarding rescue course of steroids is similarly inconsistent. 52 53 54 55 56 57 Given these inconsistencies regarding perinatal benefit to late preterm and rescue ACS, as well as the suppression of the maternal immune response associated with steroid administration, we recommend all late preterm antenatal steroids and rescue courses to be withheld during the pandemic.…”
Section: Limited Use Of Antenatal Corticosteroids Beyond 34 Weeks or mentioning
confidence: 99%
“…임신나이 34주에서 36주까지의 후기 조산은 전체 조산의 71%, 모든 분만의 약 8.7%를 차지한다고 알려져 있다 1) . 후기 조산아는 34주 이전에 태어나는 조산아들에 비해 그 정도가 덜하기는 하지만 37주 이후에 태어나는 만삭아들과 비교하면 신생아 시기에 호흡곤 란으로 신생아중환자실에 입원하여 환기보조치료를 받게 되는 경 우가 많다.…”
Section: 서론unclassified
“…Especially the late PTB model, PCA30d, could be used to clarify some research questions typically encountered in this late preterm period. For example, there is still a heated debate around the question on how to address growth restriction [40] during this specific gestation and subsequently the infant respiratory [41] and neonatal morbidity [10,42].…”
Section: Plos Onementioning
confidence: 99%